# Clinical Integration Guidelines

## Clinical Decision Analysis

**CI1.1** - **Clinical Objective Definition**
- **Check**: Clear clinical objectives and success metrics defined
- **Method**: Clinical stakeholder interview and documentation
- **Pass Criteria**: Clinical goals documented with measurable outcomes
- **Severity**: BLOCKER

**CI1.2** - **Cost-Benefit Analysis**
- **Check**: Clinical costs of false positives/negatives quantified
- **Method**: Clinical cost modeling with domain experts
- **Pass Criteria**: Cost ratios documented and used in threshold optimization
- **Severity**: WARNING

**CI1.3** - **Clinical Workflow Integration**
- **Check**: Model fits into existing clinical workflow
- **Method**: Workflow analysis and integration planning
- **Pass Criteria**: Integration plan documented with clinical team approval
- **Severity**: WARNING

## Threshold Optimization for Clinical Use

**CI2.1** - **Clinical Constraint Definition**
- **Check**: Minimum clinical performance requirements specified
- **Method**: Clinical expert consultation on acceptable performance
- **Pass Criteria**: Minimum sensitivity/specificity thresholds documented
- **Severity**: BLOCKER

**CI2.2** - **Cost-Sensitive Threshold Selection**
- **Check**: Thresholds optimized using clinical cost considerations
- **Method**: Minimize expected clinical cost or maximize clinical utility
- **Pass Criteria**: Threshold selection incorporates clinical cost ratios
- **Severity**: WARNING

**CI2.3** - **Constraint Feasibility Check**
- **Check**: Clinical constraints are achievable with available data
- **Method**: ROC analysis to verify constraint feasibility
- **Pass Criteria**: Required performance levels achievable or constraints adjusted
- **Severity**: BLOCKER

## Clinical Validation Requirements

**CI3.1** - **Domain Expert Review**
- **Check**: Clinical domain experts review model features and predictions
- **Method**: Structured clinical review process
- **Pass Criteria**: Clinical team approves feature selection and model logic
- **Severity**: WARNING

**CI3.2** - **Edge Case Analysis**
- **Check**: Model behavior on clinical edge cases evaluated
- **Method**: Test model on rare but clinically important cases
- **Pass Criteria**: Model performance on edge cases documented
- **Severity**: INFO

**CI3.3** - **Bias and Fairness Assessment**
- **Check**: Model fairness across patient subgroups evaluated
- **Method**: Subgroup analysis by demographics and clinical characteristics
- **Pass Criteria**: No significant bias detected or bias mitigation implemented
- **Severity**: WARNING

## Interpretability and Explainability

**CI4.1** - **Feature Importance Clinical Validation**
- **Check**: Top model features align with clinical knowledge
- **Method**: Clinical expert review of feature importance rankings
- **Pass Criteria**: Feature importance clinically sensible and validated
- **Severity**: WARNING

**CI4.2** - **Prediction Explanation Capability**
- **Check**: Model provides interpretable predictions for clinical use
- **Method**: SHAP, LIME, or similar explanation method implemented
- **Pass Criteria**: Individual prediction explanations available and clinically interpretable
- **Severity**: INFO

## Regulatory and Compliance

**CI5.1** - **Clinical Guidelines Compliance**
- **Check**: Model development follows relevant clinical guidelines
- **Method**: Compliance checklist against applicable standards
- **Pass Criteria**: All relevant guidelines addressed
- **Severity**: BLOCKER

**CI5.2** - **Documentation Completeness**
- **Check**: Complete documentation for clinical and regulatory review
- **Method**: Documentation audit against requirements
- **Pass Criteria**: All required documentation complete and accessible
- **Severity**: BLOCKER

## Deployment Readiness

**CI6.1** - **Clinical Testing Plan**
- **Check**: Plan for prospective clinical validation defined
- **Method**: Prospective study design with clinical endpoints
- **Pass Criteria**: Clinical validation study designed and approved
- **Severity**: WARNING

**CI6.2** - **Monitoring Strategy**
- **Check**: Continuous monitoring plan for deployed model
- **Method**: Performance drift detection and clinical outcome tracking
- **Pass Criteria**: Monitoring plan includes clinical outcome measures
- **Severity**: WARNING

**CI6.3** - **Failure Mode Documentation**
- **Check**: Known failure modes and limitations documented
- **Method**: Systematic analysis of model limitations
- **Pass Criteria**: Failure modes documented with mitigation strategies
- **Severity**: INFO
